Friday, January 19, 2024

COVID-19 Updates

Received this email from a friend? Sign up now

CDC Centers for Disease Control and Prevention CDC 24/7: Saving Lives, Protecting People
Coronavirus Disease 2019 (COVID-19)
January 19, 2024
Amount of Respiratory Illness Is Elevated or Increasing in Most Areas of the Country
Graphic of man showing his band aid

Respiratory Virus Data Channel Weekly Snapshot


The amount of respiratory illness (fever plus cough or sore throat) causing people to seek healthcare is elevated or increasing across most areas of the country. CDC’s Respiratory Virus Data Channel provides a summary of the key viral respiratory illness findings for COVID-19, flu, and RSV. CDC continues to anticipate this fall and winter respiratory illness season will likely result in a similar number of hospitalizations as last season. Vaccination remains the best way to protect yourself against serious outcomes of COVID-19, flu, and RSV (if eligible for RSV vaccine). 

Graphic of man showing his band aid

Where to Find FREE COVID-19 Testing 


CDC’s Increasing Community Access to Testing (ICATT) program will continue to provide no-cost COVID-19 testing for uninsured people who are symptomatic or exposed. More than 19,000 ICATT sites will also offer no-cost COVID-19 vaccines to adults without health insurance and adults without full vaccine insurance coverage. This website helps you find ICATT COVID-19 testing locations and contact information for the providers. You can also visit your state, tribal, local, or territorial health department’s website to find the latest local information on testing.


Graphic of diverse group of people showing their band aids

Benefits of Antiviral Treatment for COVID-19 Outweigh Potential Risks of Rebound


If you get sick with COVID-19 and are at higher risk for severe illness, antiviral treatments are available that can reduce your risk of hospitalization and death. But it’s important to get on treatment within 5-7 days after you first develop symptoms.


Rebound, a return of symptoms or a new positive test after having tested negative, has been reported in people with and without the use of COVID-19 antivirals. Current evidence suggests rebound presents as mild symptoms 3-7 days after initial illness resolves. If you are at high risk for severe COVID-19, treatment benefits outweigh the potential risks of rebound.


graphic of a graph of covid cases

Updated Guidance for Healthcare Providers on Increased Supply of RSV Immunization to Protect Babies


Nirsevimab is an RSV antibody immunization recommended for preventing severe RSV in infants and some young children. Supply of nirsevimab was limited earlier in the season, and CDC provided guidance to healthcare providers on how to prioritize the limited supply. But with recent increases in supply, CDC now advises healthcare providers to return to recommendations put forward by CDC and the Advisory Committee on Immunization Practices (ACIP) on the use of nirsevimab in babies and young children. Infants and children recommended to receive nirsevimab should be immunized as quickly as possible. RSV antibody immunization is recommended for all infants who are younger than 8 months, born during or entering their first RSV season, and some children between 8-19 months who are at increased risk for severe RSV and entering their second RSV season. Most infants whose mothers received an RSV vaccine do not need to also get an RSV antibody.


Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe

Friday, December 22, 2023

Antivirals Can Protect Against Severe Illness from COVID-19. Take Advantage.

Received this email from a friend? Sign up now

CDC Centers for Disease Control and Prevention CDC 24/7: Saving Lives, Protecting People
Coronavirus Disease 2019 (COVID-19)
December 22, 2023
This message includes updates on COVID-19 from CDC.

Antivirals and COVID-19

Antivirals are an important tool for treating people with COVID-19 but are often underused. COVID-19 antivirals help reduce hospitalizations and deaths among people at higher risk, especially people 65 years and older and those with certain underlying conditions. COVID-19 antivirals need to be prescribed more often to people who are at risk for severe illness to reduce hospitalizations and save lives.

If You Get Sick with COVID-19, Antiviral Treatments Can Protect You Against Severe Illness

With COVID-19 hospitalizations on the rise, it is important that people who get sick and are at higher risk for severe illness get on treatment in the first days of illness, since symptoms can change and worsen quickly. While these antivirals are effective at preventing severe disease, not enough people are taking them.


Antivirals can provide additional protection, even if you are vaccinated, if:

  • You are at least 50 years of age, especially 65 and older, OR
  • You have certain underlying medical conditions, such as a weakened immune system, heart disease, obesity, diabetes, or chronic lung disease, regardless of your age

If you get sick with COVID-19, you should talk to a medical provider about getting treatment if you fall into either of these two categories. Find out more.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe

Friday, December 15, 2023

Health Alert Network (HAN) Update on COVID-19 and Other Respiratory Illness Increases

Received this email from a friend? Sign up now

CDC Centers for Disease Control and Prevention CDC 24/7: Saving Lives, Protecting People
Coronavirus Disease 2019 (COVID-19)
December 15, 2023
This message includes updates on COVID-19 from CDC.

Respiratory Illnesses Are on the Rise. There Is Still Time to Get 

Vaccinated


Respiratory illness activity is rapidly increasing across the United States, yet vaccination rates for COVID-19, influenza, and respiratory syncytial virus (RSV) remain low. Millions of people may get sick in the next month or two, and low vaccination rates means more people will get more severe disease. Getting vaccinated now can help prevent hospitalizations and save lives.


CDC is reaching out to healthcare providers and clinicians to encourage them to recommend all patients receive all respiratory immunizations they are eligible for. On December 14, CDC issued a Health Alert Network (HAN) advisory to raise awareness about respiratory illness activity and urge action. To increase vaccination coverage, COVID-19 vaccines are available at no cost to people who are uninsured or underinsured through the Bridge Access Program.


Respiratory illness activity is rising


COVID-19 hospitalizations are rising quickly. Since the summer, public health officials have been tracking a rise in multisystem inflammatory syndrome in children (MIS-C), which is caused by COVID-19. Influenza activity is growing in most parts of the country. RSV activity remains high in many areas. In some parts of the country, hospital beds for children are already nearly as full as they were this time last year. If these trends continue, the situation at the end of this month could again strain emergency departments and hospitals, as it did in winter 2022-2023. Strain on the healthcare system could mean that patients with other serious health conditions may face delays in receiving care.


On December 14, CDC issued a Health Alert Network (HAN) advisory to healthcare providers and public health officials highlighting the increased respiratory disease activity occurring in the United States, particularly in the southern part of the country, and internationally. The HAN noted that low vaccination rates for COVID-19, influenza, and RSV could lead to more severe disease and a strained healthcare system for the rest of the season. These low rates can also lead to more days of missed work and school.


There’s still time to get vaccinated. Talk with your trusted healthcare provider about which vaccines you and your loved ones need to stay healthy this holiday season and into the new year. Find out more.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe

Wednesday, December 13, 2023

The Delivery - Remarkable stories from the COVID-19 vaccine delivery efforts

Update your preferences

  ...